Application 050730
- Type
- NDA
- Sponsor
- PFIZER
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ZITHROMAX | AZITHROMYCIN | TABLET;ORAL | EQ 600MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | Yes | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N050730-001 | ZITHROMAX | AZITHROMYCIN | EQ 600MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1996-06-12 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-09-29 23:25 UTC | 2022-09 | N050730-001 | ZITHROMAX | EQ 600MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1996-06-12 | e64feba35796… | |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N050730-001 | ZITHROMAX | EQ 600MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1996-06-12 | cb3db0bc1861… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N050730-001 | ZITHROMAX | EQ 600MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1996-06-12 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-07-19 19:46 UTC | 2019-07 | N050730-001 | AB | 1 | ea99ee380514… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Azithromycin | AZITHROMYCIN | NuCare Pharmaceuticals,Inc. | 94e17ae5-0871-67a0-e053-2995a90ae0ae | 2026-09-09 | Warnings, Adverse reactions | AZITHROMYCIN |
| azithromycin | AZITHROMYCIN | REMEDYREPACK INC. | da399401-1ee6-422a-be46-0bba6b264b2f | 2026-09-08 | Warnings, Adverse reactions | AZITHROMYCIN |
| Azithromycin | AZITHROMYCIN | Aurobindo Pharma Limited | 3c902990-b870-4725-b9fe-76b8be633e1c | 2026-09-03 | Warnings, Adverse reactions | AZITHROMYCIN |
| azithromycin | AZITHROMYCIN | Major Pharmaceuticals | 814abe38-da4a-48af-bf4b-2ce04a5aabd1 | 2026-09-02 | Warnings, Adverse reactions | AZITHROMYCIN |
| azithromycin | AZITHROMYCIN | REMEDYREPACK INC. | bf061799-cdef-40f8-b1ce-bc5eb609f8c3 | 2026-09-02 | Warnings, Adverse reactions | AZITHROMYCIN |
| Azithromycin | AZITHROMYCIN | Aurobindo Pharma Limited | 795c13cd-e9ca-481b-9fa9-2890bdf9dac8 | 2026-09-02 | Warnings, Adverse reactions | AZITHROMYCIN |
| azithromycin | AZITHROMYCIN | Lupin Pharmaceuticals, Inc. | 01649d79-4677-4577-a3e4-e054f3f9fc3b | 2026-08-20 | Warnings, Adverse reactions | AZITHROMYCIN |
| azithromycin | AZITHROMYCIN | Lupin Pharmaceuticals, Inc. | c9990a1d-5238-403e-9221-72a9314d7b5e | 2026-08-20 | Warnings, Adverse reactions | AZITHROMYCIN |
| Azithromycin | AZITHROMYCIN | Zydus Pharmaceuticals USA Inc. | 99e5bd22-a721-4e2e-a46c-d61a53c25c3d | 2026-08-14 | Warnings, Adverse reactions | AZITHROMYCIN |
| Azithromycin | AZITHROMYCIN | REMEDYREPACK INC. | 614cc2a4-3fc7-455d-9e8a-212c496f0fbf | 2026-08-05 | Warnings, Adverse reactions | AZITHROMYCIN |
| Azithromycin | AZITHROMYCIN | Sandoz Inc | 34b70c23-92a6-460f-8dbb-15a0e6b9d3a9 | 2026-07-30 | Warnings, Adverse reactions | AZITHROMYCIN |
| Azithromycin | AZITHROMYCIN | NuCare Pharmaceuticals,Inc. | a9cdb5ae-2aeb-c598-e053-2a95a90a8062 | 2026-07-30 | Warnings, Adverse reactions | AZITHROMYCIN |
| Azithromycin | AZITHROMYCIN | Sandoz Inc | ec619299-e0ef-44dd-acdb-8c53bbfc5b8a | 2026-07-30 | Warnings, Adverse reactions | AZITHROMYCIN |
| Azithromycin | AZITHROMYCIN | A-S Medication Solutions | 882f71b1-b153-4856-b4a7-1a29ae9cf247 | 2026-07-29 | Warnings, Adverse reactions | AZITHROMYCIN |
| Azithromycin | AZITHROMYCIN | Eugia US LLC | 7b81436e-d14a-4353-a22d-253f45e2e576 | 2026-07-27 | Warnings, Adverse reactions | AZITHROMYCIN |
| Zithromax | AZITHROMYCIN DIHYDRATE | Pfizer Laboratories Div Pfizer Inc | db52b91e-79f7-4cc1-9564-f2eee8e31c45 | 2026-07-24 | Warnings, Adverse reactions | Zithromax |
| Zithromax | AZITHROMYCIN DIHYDRATE | Pfizer Laboratories Div Pfizer Inc | 3b631aa1-2d46-40bc-a614-d698301ea4f9 | 2026-07-24 | Warnings, Adverse reactions | Zithromax |
| Azithromycin | AZITHROMYCIN | A-S Medication Solutions | 3b7e16b1-9a3c-4e3a-8411-841a708afe45 | 2026-07-23 | Warnings, Adverse reactions | AZITHROMYCIN |
| Azithromycin | AZITHROMYCIN | A-S Medication Solutions | 58308e8b-57bd-4e82-a2e8-24aac63194cd | 2026-07-23 | Warnings, Adverse reactions | AZITHROMYCIN |
| Azithromycin | AZITHROMYCIN | Bryant Ranch Prepack | 2a8010dc-700f-45d3-94ca-ebe4a51acc1b | 2026-07-20 | Warnings, Adverse reactions | AZITHROMYCIN |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0069-3080 | ZITHROMAX | AZITHROMYCIN DIHYDRATE | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-3080 | ZITHROMAX | AZITHROMYCIN DIHYDRATE | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-3080 | ZITHROMAX | AZITHROMYCIN DIHYDRATE | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-3080 | ZITHROMAX | AZITHROMYCIN DIHYDRATE | Pfizer Laboratories Div P | NDA | Current |
| 59762-3080 | azithromycin | AZITHROMYCIN | Greenstone LLC | NDA | Current |
| 59762-3080 | azithromycin | AZITHROMYCIN | Greenstone LLC | NDA | Current |
| 59762-3080 | azithromycin | AZITHROMYCIN | Greenstone LLC | NDA | Current |
| 59762-3080 | azithromycin | AZITHROMYCIN | Greenstone LLC | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 69393 | SUPPL | 2021-11-23 |
| 69374 | SUPPL | 2021-11-22 |
| 58433 | SUPPL | 2019-04-26 |
| 58414 | SUPPL | 2019-04-25 |
| 47837 | SUPPL | 2017-04-03 |
| 47784 | SUPPL | 2017-03-30 |
| 47184 | SUPPL | 2017-02-13 |
| 47183 | SUPPL | 2017-02-10 |
| 30400 | SUPPL | 2016-05-25 |
| 18139 | SUPPL | 2016-05-25 |
| 8137 | SUPPL | 2014-06-11 |
| 39208 | SUPPL | 2014-06-10 |
| 23725 | ORIG | 2013-03-12 |
| 39210 | SUPPL | 2013-02-21 |
| 8139 | SUPPL | 2013-02-21 |
| 39207 | SUPPL | 2012-11-06 |
| 30399 | SUPPL | 2012-11-06 |
| 39209 | SUPPL | 2012-06-11 |
| 8138 | SUPPL | 2012-06-08 |
| 18138 | SUPPL | 2011-02-04 |
| 30398 | SUPPL | 2011-02-03 |
| 39206 | SUPPL | 2010-08-19 |
| 8136 | SUPPL | 2010-08-17 |
| 39205 | SUPPL | 2009-04-23 |
| 8135 | SUPPL | 2009-03-10 |
| 8134 | SUPPL | 2007-11-08 |
| 39204 | SUPPL | 2007-11-07 |
| 39203 | SUPPL | 2004-04-05 |
| 30396 | SUPPL | 2004-03-28 |
| 30397 | SUPPL | 2004-01-22 |
| 30395 | SUPPL | 2002-10-16 |
| 8133 | SUPPL | 2002-07-22 |
| 39202 | SUPPL | 2000-11-13 |
| 30394 | SUPPL | 2000-11-13 |
| 22210 | SUPPL | 2000-11-13 |